Edition:
United States

Sierra Oncology Inc (SRRA.OQ)

SRRA.OQ on NASDAQ Stock Exchange Global Market

1.35USD
3:59pm EST
Change (% chg)

$-0.01 (-0.74%)
Prev Close
$1.36
Open
$1.36
Day's High
$1.38
Day's Low
$1.34
Volume
16,291
Avg. Vol
66,027
52-wk High
$3.70
52-wk Low
$1.07

Chart for

About

Sierra Oncology, Inc., formerly ProNAi Therapeutics, Inc., is a clinical-stage drug development company. The Company’s lead drug candidate, SRA737, is orally bioavailable small molecule inhibitor of Checkpoint kinase 1 (Chk1), a key cell cycle checkpoint and central regulator of the deoxyribonucleic acid (DNA) Damage Response... (more)

Overall

Beta: 1.71
Market Cap(Mil.): $120.84
Shares Outstanding(Mil.): 74.37
Dividend: --
Yield (%): --

Financials

  SRRA.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -0.63 -- --
ROI: -39.36 0.60 13.80
ROE: -40.27 -2.18 15.29

Earnings vs. Estimates